Tenderwize
Back to tender search

Italy – Administrative healthcare services – PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL

FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI·MILANO, Italy·EUR 2M·Deadline Nov 24, 2026 · 18 days left·Open·Services
High value
0/100

Opportunity Score

High riskLow complexity
ServicesOpen
Why this score?

Opportunity

0 / 100

Complexity

0 / 100

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
Country
Italy
CPV
75122000 - Administrative healthcare services
Deadline
Nov 24, 2026
Estimated value
EUR 2M

AI tender analysis

Tenderwize prepares an AI analysis of this tender based on the TED notice and procurement documents: scope of work, key requirements, eligibility criteria, risks and questions for the buyer. The analysis is generated when the tender is opened.

Buyer

Location

MILANO, ITA

Identifier

80018230153

Activity

Health

Lots (1)

LOT-0001

PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL

PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL PREVISTA CLAUSOLA DI ADESIONE EX-POST A FAVORE DEGLI ENTI DEL CONSORZIO COMPRESA LA FONDAZIONE DEL 300%, COME DA ART. 2 DEL DISCIPLINARE DI GARA

ServicesEU fundedElectronic submission

EUR 2M

Estimated value

Duration

Nov 2026 - Nov 2026

Category

Administrative healthcare services

Procurement Details

Publication date
03 Nov 2026
Languages
Italian

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
766672-2026

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy